Quality Policy

Depofarma focuses its activities on the development and commercialization of products, such as cosmetics, dietary supplements, and medical devices, that are able to meet patients’ needs while ensuring high quality and effectiveness.

To achieve this goal, Depofarma is committed to continuously improving all aspects of its activities, including:
– research and development, with constant technical and scientific updates;
– the use and study of the best raw materials and careful selection of suppliers;
– the involvement of all employees and a strong focus on training;
– monitoring developments in the cosmetics, nutraceuticals, and medical devices markets;
– ensuring the adequacy of the organizational structure and the resources employed.

These aspects are harmonized and properly integrated within a Quality Management System, compliant with UNI EN ISO 9001:2015 and UNI CEI EN ISO 13485:2021 standards and, with regard to the medical devices manufactured by Depofarma, in compliance with the applicable regulations (Directive 93/42/EEC and subsequent amendments, and Regulation (EU) 2017/745).

In this regard, we have analyzed the overall context in which we operate (both internal and external), identified the interested parties, and consequently carried out a risk and opportunity analysis related to our activities, leading to the development of appropriate improvement actions.

Compliance with the standards has enabled quality management in all its aspects, documenting the procedures and highlighting the various factors that contribute to business improvement.

In conclusion, the commitment of the General Management and all company staff remains consistently focused on:
– Continuously striving for improvement;
– developing and delivering high-quality products and services that meet customer requirements and applicable standards or regulations in a timely and successful manner;
– maintaining and implementing an effective Quality Management System.